Dr. Weiner studies liver transplantation, specifically looking at how to enhance surgical techniques to improve patient outcomes. His research involves using animal models, particularly cynomolgus macaques, to explore new methods that can prevent complications during surgery. One significant area of focus is a novel vein bypass technique designed to maintain blood flow when the liver is temporarily not in place, which is crucial for successful transplants.
Key findings
Implemented an H-shaped vein bypass in liver transplant surgeries leading to improved survival rates during the critical no-liver phase.
Demonstrated a significant increase in surgical survival for liver transplants using this new technique in cynomolgus macaques, although specific survival rates were not quantified in the summary.
Enabled more reliable liver transplant models for future research, facilitating potential advancements in human liver transplantation.
Frequently asked questions
Does Dr. Weiner study liver transplantation?
Yes, Dr. Weiner focuses specifically on improving surgical techniques for liver transplantation.
What innovative techniques has Dr. Weiner researched?
He has developed a novel H-shaped vein bypass to improve blood flow during liver transplant surgeries.
Is Dr. Weiner's work relevant to patients needing liver transplants?
Yes, his research aims to improve surgical outcomes for liver transplant patients by addressing complications during surgery.
Publications in plain English
Allogeneic, Xenogeneic, and Exogenic Hearts for Transplantation.
Plain English This study looked at new ways to provide hearts for transplant when human donors are in short supply. Researchers found that genetically modified pig hearts could be successfully transplanted into baboons, and two patients who received these pig hearts survived for up to 2 months. Solving remaining challenges could allow patients to survive even longer, which would greatly increase the availability of hearts for transplantation.
Who this helps: This benefits patients with end-stage heart failure who need a transplant.
Xenotransplantation and exotransplantation: Strategies to expand the number of donor organs.
2023
Xenotransplantation
Garry DJ, Weiner JI, Greising SM, Sachs DH, Garry MG
Plain English This research looks at two methods—using animal organs and a technique to create specially designed pigs—to increase the number of organs available for heart transplants. The authors believe these approaches could lead to a nearly limitless supply of organs for patients with severe heart disease. This is important because the current shortage of donor organs leads to many preventable deaths.
Who this helps: This benefits patients with heart disease who need organ transplants.
Human muscle in gene edited pigs for treatment of volumetric muscle loss.
2022
Frontiers in genetics
Greising SM, Weiner JI, Garry DJ, Sachs DH, Garry MG
Plain English This study looked at how to treat injuries where large amounts of muscle are lost, especially from severe trauma. Researchers found that using human muscle grown in gene-edited pigs could offer a promising solution for these injuries. This new approach could help address challenges that current treatments face, potentially leading to better recovery options for patients.
Who this helps: This helps patients recovering from severe muscle loss due to injuries.
Mechanisms and strategies to promote cardiac xenotransplantation.
2022
Journal of molecular and cellular cardiology
Garry DJ, Weiner JI, Greising SM, Garry MG, Sachs DH
Plain English This research paper focuses on heart transplants from genetically modified pigs to humans, a process known as cardiac xenotransplantation, to address the shortage of human donor hearts. The paper discusses advancements in gene editing that enable pig organs to be potentially safe for human use, including successful experiments where pig hearts were transplanted into humans. This is important because it could provide new heart options for patients facing end-stage heart failure when human organs are not available.
Who this helps: Patients with severe heart failure who need a transplant.
Novel H-shunt Venovenous Bypass for Liver Transplantation in Cynomolgus Macaques.
2017
Comparative medicine
Kato Y, Griesemer AD, Wu A, Sondermeijer HP, Weiner JI +7 more
Plain English Liver transplant experiments in cynomolgus monkeys are hampered by the animals' poor tolerance of portal vein clamping during surgery. This study developed and tested an H-shaped vein bypass to maintain blood flow during the critical no-liver phase, dramatically improving surgical survival. The technique enables more reliable primate liver transplant models for future research.
Distinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus Macaques.
2016
Comparative medicine
Zitsman JS, Alonso-Guallart P, Ovanez C, Kato Y, Rosen JF +2 more
Plain English This study looked at the immune cells in the blood and organs of cynomolgus macaques, a type of monkey often used in medical research. Researchers found that these macaques have a lower ratio of one type of immune cell (CD4 to CD8 T-cells) compared to humans, and their blood contains a unique set of immune cells that isn’t typically found in people. Understanding these differences is important for scientists conducting immunology research to ensure they accurately interpret their findings.
Who this helps: This helps researchers and veterinarians working with cynomolgus macaques in various settings.
Ex vivo pancreaticoduodenectomy and liver autotransplantation for pancreatic head tumor with extensive involvement of the hepatoduodenal ligament.
2015
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Matsuoka N, Weiner JI, Griesemer AD, Samstein BB, Zhao Y +2 more
Daniel J Garry Mary G Garry David H Sachs Sarah M Greising Yojiro Kato Adam D Griesemer Raimon Duran-Struuck Tomoaki Kato Hiromitsu Nakauchi Hideki Masaki
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.